August 23, 2016 — IBA (Ion Beam Applications S.A.) announced the first worldwide clinical implementation of its newly released Dolphin Online Ready Patient QA and Monitoring. The team at the Radiation Therapy department of the Klinikum Bayreuth GmbH in Bayreuth, Germany, has successfully validated and clinically implemented three Dolphin systems at two of their sites.
This milestone allows the clinic to set a trend in terms of radiation therapy treatment quality. Compared to conventional quality assurance (QA) solutions, Dolphin provides a significantly higher treatment dose measurement resolution and capability to detect and verify possible dose discrepancies. Patient QA workflow efficiency is increased with Dolphin’s “plug and play” wireless design and instant setup.
“We are proud to provide the highest level of treatment quality and safety to all our patients. Prior to each patient treatment, an intensive quality assurance is performed with Dolphin. This is our basis to achieve the highest QA standards today and in the future,” said Mathias Dierl, head of medical physics at the Klinikum Bayreuth.
The Dolphin dose measurements are analyzed with a sophisticated TPS-Class verification software package; the instant verification functionality provides automatic analysis and displays an “OK” message for the tests that have successfully passed. The clinical relevance of the patient dose discrepancies can be comprehensively determined in 3-D patient anatomy with DVH and Oran-at-Risk pass/fail analysis.
At the clinic in Bayreuth, highly complex intensity-modulated radiation therapy (IMRT) treatment plans are delivered and measured with Dolphin prior to each patient treatment. The sophisticated TPS-Class software allows verification of dose deviations in 3-D between the plan and delivered, as well as Dolphin-measured actual dose in the patient’s anatomy.
For more information: www.iba-worldwide.com
March 28, 2024 
